🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in individuals injecting substances of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.

Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or prison.

Service Response and Material Elimination

Based on the social media company, the service has removed problematic material and banned related keywords and search suggestions. The company said it was committed to maintaining the service safe and investing in strengthening compliance measures.

Online Trading Activities

Research also discovered groups with up to nine thousand members selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, populated with photos of slimming results, positive testimonials and step-by-step guides for mixing or administering at residence.

Within moments of entering one group, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.

Product Information and Pricing

Within these communities, posts show black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how long a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for Telegram stated it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they cannot confirm. Even if the research behind this drug is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has previously seen individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose users to potentially significant medical dangers”.